As the industry transitions to single-use processes, replacing reusable packed bed columns with single-use solutions continues to be a challenge. Join 3M as they discuss the major considerations and requirements to replace a polishing anion exchange (AEX) column in a recombinant mAb process from laboratory to manufacturing scale.
3M will also present their single-use high-performance AEX polishing chromatography solution to enable a rapid and robust transition away from reusable packed beds and discuss the economic impact of such a transition.
Dr. Hani El-Sabbahy is an Advanced Application Engineering Specialist, based in the UK, specialized in biopharmaceutical purification. He partners with global biopharmaceutical manufacturers to replicate or develop applications and deploy new 3M purification technologies. He also leads various collaborative research efforts. Prior to joining 3M, he worked as a Senior Downstream Process Development Scientist at Actavis Biologics as an expert in continuous downstream processing. He has 15 years of experience in downstream process development for biopharmaceuticals and obtained his PhD in Biochemical Engineering from University College London (UCL).
Dr. Alexei Voloshin is the Global Application Development Manager in the 3M Separation and Purification Sciences Division. He is responsible for developing and managing new applications and bioprocess technology strategy at 3M, and manages Bioprocess industry collaborations around the globe.
Alexei brings more than 15 years of experience in bio-process development, as well as technical, operational, and business knowledge in the biotechnology field.
Before joining 3M, Alexei held various leadership positions in bio-process development at TheraOne, Theranos, and Sutro Biopharma. He has authored a number of publications and presentations dealing with novel bio-processes and their applications to making advanced bio-therapeutics.
Alexei got his Ph.D. in Chemical Engineering from Stanford University and Bachelor of Chemical Engineering and B.S. in Computer Science from the University of Minnesota Twin Cities.
Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.